Dysregulated activity of GSK-3β is associated with several diseases such as type 2 diabetes, heart disease, chronic inflammatory diseases, neurodegenerative diseases, and cancer, therefore, GSK-3β inhibition is a potential approach for the treatment of these diseases30,.50 This evidence concerns the gene GSK3B and neurodegenerative disease.